Browse the evidence

Increases in total and moderate-to-vigorous physical activity (MVPA) during the post-weight loss maintenance phase are associated with less weight regain (or greater weight loss) one year after the intervention.

After you reach your weight loss goal, don't stop moving. This study found that people who kept up or increased their moderate-to-vigorous exercise (like brisk walking or jogging) after losing weight were much more likely to keep it off one year later. Treat your post-goal activity as a permanent part of your lifestyle, not just a tool for getting to the goal.

A 3-month calorie-restricted ketogenic diet (KD) produces significantly greater weight loss than a calorie-restricted Mediterranean diet (MedDiet) in adults with obesity.

To lose more weight than a standard Mediterranean diet in 3 months, switch to a ketogenic diet with a 600-calorie daily deficit. This means eating very few carbs (5% of calories), moderate protein (30%), and high fat (65%). Ensure you are consuming enough calories to maintain basic function but below your maintenance level.

Modified Alternate-Day Fasting (mADF) produces significantly greater weight loss than a calorie-restricted Mediterranean diet (MedDiet) in adults with obesity.

Try modified alternate-day fasting: eat normally (but within your calorie limit) 4 days a week, and restrict calories to 400-800 on the other 3 days. This approach may yield better weight loss than a standard Mediterranean diet.

Late Time-Restricted Eating (lTRE) with an 8-hour window (2 pm - 10 pm) produces significantly greater weight loss than a calorie-restricted Mediterranean diet (MedDiet) in adults with obesity.

Try late time-restricted eating: restrict your eating to an 8-hour window from 2 pm to 10 pm. Ensure you are eating a balanced diet (45% carbs, 20% protein, 35% fat) with a 600-calorie daily deficit. This may yield better weight loss than a standard Mediterranean diet.

Weekly administration of semaglutide at 2.4 mg induces significant weight loss (mean 14.9%) and improves glycemic control (HbA1c < 7.0% in 57-74% of patients) in adults with obesity or type 2 diabetes, with effects proportional to dose and duration.

If you have obesity or type 2 diabetes, weekly semaglutide (2.4 mg for weight loss, 1-1.0 mg for diabetes) is a highly effective treatment that can lead to significant weight loss (up to 15%) and better blood sugar control. While nausea and vomiting are common side effects, they are usually mild and temporary, and weight loss often occurs regardless of whether you experience them. An oral version is also available if you prefer to avoid injections. Discuss this with your doctor to see if it's right for you.

Tirzepatide produces significantly greater weight loss than semaglutide in overweight and obese adults, with a standardized mean difference of 0.75 favoring tirzepatide.

If you are choosing between tirzepatide and semaglutide for weight loss, current direct comparative evidence suggests tirzepatide may lead to greater weight reduction. This benefit comes with a dual-hormone mechanism (GIP/GLP-1) and requires weekly injections. You should expect potential gastrointestinal side effects during dose increases, which are usually manageable. Combining the medication with diet and exercise will likely enhance results.

Tirzepatide significantly increases the odds of achieving clinically meaningful weight loss (≥10% body weight reduction) compared to semaglutide.

A key benefit of tirzepatide over semaglutide is the increased likelihood of losing 10% or more of your body weight, a threshold often associated with significant health improvements. This makes tirzepatide a potentially more effective option if your primary goal is substantial weight reduction. Discuss with your provider whether this higher efficacy profile aligns with your health goals.

Caloric restriction is the primary and most effective method for weight loss in obesity treatment, regardless of macronutrient composition.

To lose weight effectively, focus on reducing your total daily calories rather than obsessing over specific macronutrient ratios. Aim for a daily intake of approximately 25 kcal per kg of your standard body weight. If you have severe obesity (BMI ≥ 35), start with 20-25 kcal/kg. A modest weight loss of 3-5% of your current body weight is sufficient to improve health risks like high blood pressure and blood sugar. Combine this with behavioral changes like self-monitoring and adequate protein intake to preserve muscle mass.

Behavioral interventions, including self-monitoring of weight and food habits, are essential for maintaining weight loss and preventing rebound in obesity treatment.

To keep weight off, adopt behavioral strategies. Weigh yourself 4 times a day (morning, after breakfast, after dinner, before bed) and graph your weight to track trends. Use a '30-chewing method' to slow down eating and improve satiety signals. Keep a diet behavior questionnaire to identify triggers for overeating, such as stress or emotional eating. Remember that small improvements are valuable, and perfection is not required for success.

Oral semaglutide (50 mg once daily) is effective for weight loss in non-diabetic obese/overweight adults, though generally less effective than the subcutaneous 2.4 mg formulation.

If you prefer not to use injections, oral semaglutide (50 mg daily) is a viable option for weight loss in non-diabetic adults with obesity. It produces significant weight loss (average 15%), though it requires daily adherence. It is generally considered less effective than the weekly injectable form, so discuss with your provider which form best fits your lifestyle and medical needs.

Aerobic physical activity (30-60 minutes, moderate to vigorous intensity, most days) improves cardiometabolic risk factors and reduces visceral fat, even without significant weight loss.

Aim for 30-60 minutes of moderate to vigorous aerobic exercise most days of the week. This will reduce dangerous visceral fat and improve your blood pressure and blood sugar, even if you don't lose much weight on the scale.

Consumers can verify supplement quality and safety by seeking products that undergo third-party testing (e.g., NSF, Informed Choice) and adhere to Good Manufacturing Practices (cGMPs).

To ensure you are getting what is on the label and avoiding banned substances, look for third-party testing seals like NSF International or Informed Choice. These organizations test products for purity and adherence to Good Manufacturing Practices (cGMPs). You can also request certificates of analysis from manufacturers to verify quality.

Limiting consumption of sugar-sweetened beverages (SSBs) is a critical intervention for weight control and obesity prevention.

Cut out sugary sodas and sweetened juices. Replacing them with water or non-caloric beverages is one of the most effective single changes for preventing weight gain, especially in children.

Moderate intensity physical activity (150-250 min/week) prevents weight gain, while >250 min/week is required for weight maintenance after loss.

To keep weight off, aim for more than 250 minutes of moderate exercise per week. To prevent gaining weight, 150-250 minutes is sufficient. Do not rely on exercise alone for weight loss; combine it with dietary changes.

In resistance-trained men, increasing training volume from 1 set to 5 sets per exercise per session significantly enhances muscle hypertrophy (specifically in elbow flexors, mid-thigh, and lateral thigh) without providing additional strength or endurance benefits.

If you are an experienced lifter, doing 1 set per exercise to failure is enough to build strength and endurance, saving you significant time. However, if your primary goal is maximizing muscle size, you should perform 3-5 sets per exercise. The extra sets will yield more muscle growth, but you won't get stronger faster by doing them. Prioritize volume for hypertrophy, but don't expect strength to improve just by adding sets.

Subcutaneous semaglutide 2.4 mg once weekly produces 15–17% mean weight loss and offers cardioprotection in obesity treatment.

If you have obesity, subcutaneous semaglutide 2.4 mg once weekly is an approved treatment that can help you lose 15–17% of your body weight and may protect your heart. This is significantly more effective than lifestyle changes alone, which often fail to maintain weight loss long-term.

Tirzepatide, a dual GLP-1/GIP receptor agonist, achieves up to 22.5% mean weight loss in phase 3 obesity trials.

Tirzepatide is a dual-acting hormone medication (GLP-1/GIP) that can lead to up to 22.5% weight loss in clinical trials, surpassing single-agonist GLP-1 drugs. It is available for obesity management.

Oral semaglutide 50 mg once daily results in 17.4% weight loss in people with obesity without type 2 diabetes.

For those who prefer not to inject medication, oral semaglutide 50 mg once daily can achieve 17.4% weight loss in people with obesity without diabetes, comparable to the injectable version.

Resistance exercise training (RET) is as effective as aerobic exercise training (AET) for reducing the risk of chronic diseases including cardiovascular disease, type 2 diabetes, and cancer, and is superior for maintaining physical mobility in older adults.

Incorporate resistance training 2-3 times per week into your routine. You do not need to lift extremely heavy weights; moderate intensity (where you can complete 8-12 reps with some effort) is effective for reducing chronic disease risk and maintaining mobility. This is as important for your long-term health as your cardio workouts.

Resistance exercise training improves glycemic control and insulin sensitivity in older adults with type 2 diabetes or prediabetes, independent of changes in lean body mass.

If you have prediabetes or Type 2 Diabetes, adding resistance training 2-3 times a week can significantly improve your blood sugar control. Focus on progressive exercises at a moderate-to-high intensity (70-85% of your one-rep max). This works by improving how your muscles use insulin, not just by building muscle.

Resistance exercise training reduces cancer mortality and recurrence risk in cancer survivors, with benefits seen even at low-to-moderate intensities.

If you are a cancer survivor, aim to do resistance training at least once a week. Even low-to-moderate intensity exercises can significantly reduce your risk of cancer recurrence and death. This is especially important for breast and prostate cancer survivors to maintain muscle and quality of life.

Weight loss of 3-10% of baseline body weight reduces systolic and diastolic blood pressure by approximately 3 mmHg, independent of salt restriction, primarily through decreased sympathetic nervous system activity and improved insulin sensitivity.

If you have high blood pressure and are overweight, aim to lose just 3-10% of your current body weight. You do not need to reach a 'perfect' weight to see benefits; this modest loss can lower blood pressure by about 3 mmHg. Work with a dietitian to achieve this gradually using calorie reduction and behavioral strategies like appetite awareness, rather than crash dieting.

Regular physical activity, including aerobic, dynamic resistance, and isometric training, reduces blood pressure, with isometric training showing significant reductions when performed at ~30% of maximal voluntary contraction.

Engage in 150-300 minutes of moderate aerobic activity (like brisk walking) or 75-150 minutes of vigorous activity weekly. Add resistance training twice a week. If you have limited time or equipment, try isometric exercises (like wall sits or handgrips) at about 30% of your maximum effort. The key is consistency and reducing sedentary time.

Adoption of the DASH diet or similar healthy dietary patterns (high in fruits, vegetables, low-fat dairy, low in saturated fat/salt) reduces blood pressure and is recommended as a first-line intervention for hypertension management.

Adopt a DASH-style diet: eat more fruits, vegetables, and low-fat dairy, and reduce saturated fats and salt. This is a proven, first-line strategy to lower blood pressure. If cost or access is a barrier, focus on affordable staples like beans, rice, and seasonal produce, and seek guidance from healthcare providers on local resources.